SCHLAP1 and prostate cancer: Therefore, to examine the potential functional significance of the 5’ and 3’ ends of SChLAP1 in prostate cancer, we overexpressed plasmids containing these regions in parallel with full-length in two cell lines, LNCaP and 22Rv1.